In addition to being an exhibitor at the conference, the University is co-sponsoring the Translational Research Forum: From Bench to Bedside in a Bioeconomy – Government, Industry and the University Models to Catalyze Economic Growth and Patient Access, an opportunity to “explore how universities and their funding partners can move early stage research forward in order to make them attractive to developers.”
Our own W. Mark Crowell, executive director of U.Va. Innovation and associate vice president for research, will moderate the forum, which will feature remarks from Boston University President Robert A. Brown, Ph.D. on the role of universities in translational medicine and Bahija Jallal from MedImmune, who will discuss details of the multi-year collaboration between AstraZeneca and U.Va.
The forum will be held on Monday, June 18, from 1:30 p.m. in the Boston Exhibution and Convention Center, Room 205 BC, and will be co-sponsored by U.Va., Millennium: The Takeda Oncology Company and Investissment Quebec.
Be sure to also drop by the U.Va. booth in BIO’s ginormous exhibit hall: The University will exhibit as part of the Virginia Pavilion (Booth 2105, Pavilion Hall A).